Drug alert for Xenidate XL
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 4 drug alert for a small number of packs from a specific batch of Xenidate XL (methylphenidate hydrochloride; Mylan UK) prolonged-release tablets 36mg. Further information about the problem and the affected batch is available on the MHRA website.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20068886
Recommended from Pharmaceutical Press
Pharmaceutics: Drug Delivery and Targeting systematically reviews important concepts for drug delivery systems and targeting of drugs.£24.00Buy now
All you need to know about prescribing or administering drugs via enteral feeding tubes. Over 400 drug monographs as well as facts to inform clinical decision making.£52.00Buy now
Remington Education: Drug Information & Literature Evaluation teaches students how to effectively and efficiently locate and analyze up-to-date drug information and literature.£26.00Buy now